Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma 2021-06-23 09:16
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars 2021-06-23 04:16
Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division 2021-06-23 03:16
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia 2021-06-22 22:32
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform 2021-06-22 20:28
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results 2021-06-22 19:00
European Wellness Advances Clinical Trials on Precursor Stem Cells for Fertility and Immunology into China 2021-06-22 14:14
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement 2021-06-22 08:00
The Pressing Need for Early Detection of Mucormycosis during COVID-19 2021-06-21 20:00
RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19 2021-06-21 19:00
Study Results of Sintilimab in Combination with Bevacizumab Biosimilar IBI305 for the First-Line Treatment of Hepatocellular Carcinoma Published in The Lancet Oncology 2021-06-21 08:00
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL. 2021-06-20 21:00
CARsgen Therapeutics officially listing on HKEX 2021-06-19 02:57
InnoCare Presents Latest Clinical Data of Orelabrutinib at the16th International Conference on Malignant Lymphoma 2021-06-18 17:12
China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India 2021-06-18 16:15
Antengene Provides an Update on Its Latest Developments 2021-06-18 14:10
Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r) 2021-06-18 10:00
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies 2021-06-18 09:58
Eccogene announces the addition of Jacques Mizrahi, PhD to Scientific Advisory Board 2021-06-17 19:49
Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC 2021-06-17 15:41
1 237 238 239 240 241 451